Richard van Zyl-Smit, ERS 2020 – Optimising Inhaled Therapies for Asthma
Richard van Zyl-Smit (University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa) kindly took the time to speak with us about maximising the benefit of inhaler therapy and recent development being made in this field.
- What are the major unmet needs in the use of inhaled therapies for the control of asthma? (0:15)
- How can we help patients optimise their inhaler technique? (0:55)
- How can we maximise the benefits of inhaler therapy over 24 hours? (1:46)
- Which asthma patients are most likely to benefit from once daily single inhaler triple therapy? (2:39)
- What have been the most exciting recent developments in inhaler therapy? (3:49)
Speaker disclosure: Richard van Zyl-Smith has conducted clinical research trials for Novartis, AstraZeneca, Takeda, Merck, Almirall, Boehringer Ingelheim, Sanofi, Teva, Perl, Pfizer, Roche, GSK and Genetech. He has also received honoraria for academic talks from, Aspen, Pfizer, AstraZeneca, Novartis, Cipla, MSD, Roche, Jannsen, Boehringer Ingelheim and participated in advisory boards for GSK, Pfizer, AstraZeneca, Novartis, MSD and Roche.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress 2020
Share this Video
Related Videos In Asthma
Isaac Schmale, AAAAI 2023: Efficacy of dupilumab for nasal polyposis in patients with aspirin-exacerbated respiratory disease
Dupilumab is used to manage chronic rhinosinusitis with nasal polyposis, however there is limited data regarding its use in patients with aspirin-exacerbated respiratory disease (AERD). touchRESPIRATORY caught up with Dr Isaac Schmale (University of Rochester Medical Center, Rochester, NY, USA) around the aims, eligibility, methodology and findings of his study investigating the real-world outcomes of […]
Isaac Schmale, AAAAI 2023: Signs and symptoms of aspirin-exacerbated respiratory disease and its treatment paradigm
touchRESPIRATORY were delighted to speak with Dr Isaac Schmale (University of Rochester Medical Center, Rochester, NY, USA) around the signs and symptoms of aspirin-exacerbated respiratory disease (AERD), the incidence of AERD in people with asthma, the current treatment paradigm for AERD and the unmet needs in its treatment. The abstract ‘Real-world Outcomes of Dupilumab Therapy […]
Ronald Strauss, AAAAI 2023: Hot topics to explore in the field of respiratory medicine
touchRESPIRATORY were delighted to speak with a valued member of our Editorial Board for touchREVIEWS in Respiratory & Pulmonary Diseases, Dr Ronald Strauss (Case Western Reserve University; Cleveland Allergy and Asthma Center, Cleveland, OH, USA), about the areas in the field of respiratory medicine that he is most looking forward to exploring in 2023. Questions […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!